A detailed history of Man Group PLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 28,904 shares of SWTX stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,904
Previous 56,091 48.47%
Holding current value
$1.21 Million
Previous $2.11 Million 56.16%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$32.04 - $42.76 $871,071 - $1.16 Million
-27,187 Reduced 48.47%
28,904 $926,000
Q2 2024

Aug 14, 2024

BUY
$36.06 - $47.62 $2.02 Million - $2.67 Million
56,091 New
56,091 $2.11 Million
Q2 2022

Aug 15, 2022

BUY
$18.36 - $60.07 $351,685 - $1.15 Million
19,155 New
19,155 $472,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.61B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.